Malnutrition affects 30–50% of hospitalized patients and is associated with increased complications, longer hospital stays, and higher mortality. For critically ill ICU patients, appropriate nutritional support is a therapeutic intervention — not merely metabolic support — that influences immune function, wound healing, gut barrier integrity, and muscle mass preservation. ASPEN (American Society for Parenteral and Enteral Nutrition) and SCCM guidelines recommend early enteral nutrition (EN) within 24–48 hours of ICU admission for hemodynamically stable patients. Our clinical nutrition catalog includes enteral formulas, parenteral nutrition components, feeding tubes, and nutrition delivery systems.
Enteral vs. Parenteral: Default to Enteral
The gut-first principle is now firmly established in critical care nutrition: EN delivered into a functioning gastrointestinal tract is preferred over parenteral nutrition (PN) whenever possible. EN maintains enterocyte integrity, reduces bacterial translocation, supports gut-associated lymphoid tissue (GALT), and is associated with lower infectious complication rates than PN in meta-analysis. PN is indicated when: the GI tract is inaccessible (short bowel syndrome, high-output fistula, complete bowel obstruction), when EN tolerance fails despite optimal positioning and prokinetic agents, or in severely malnourished patients who cannot receive EN within 7 days.
Enteral Formula Selection
Standard polymeric formulas (Abbott Jevity, Nestlé Isosource) provide 1.0–1.5 kcal/mL and are appropriate for most patients with functioning GI tracts. Peptide-based formulas (Abbott Peptamen, Nestlé Vital) use hydrolyzed protein for patients with malabsorption, pancreatic insufficiency, or Crohn's disease. Disease-specific formulas include: renal formulas (low protein, potassium, phosphorus — e.g., Abbott Nepro), hepatic formulas (branched-chain amino acid enriched), diabetic formulas (low glycemic load — Glucerna), and immune-modulating formulas with arginine, fish oil, and antioxidants (Abbott Impact) for surgical and trauma patients. Our nutrition catalog carries the full Nestlé and Abbott clinical nutrition lines.
Tube Selection and Placement Verification
Nasogastric (NG) tubes are appropriate for short-term EN (<4 weeks) in patients with intact gag reflex and no high aspiration risk. Post-pyloric feeding (nasoduodenal or nasojejunal tubes) reduces aspiration risk and may improve EN tolerance in patients with gastroparesis or elevated GRV. For long-term EN (>4 weeks), percutaneous endoscopic gastrostomy (PEG) or jejunostomy is preferred. Radiographic confirmation of feeding tube position before initiating EN is mandatory — misplaced NG tubes in the airway have caused serious patient harm. Our nutrition section includes nasogastric tubes, jejunal feeding tubes, PEG tube care kits, and enteral feeding pumps and extension sets.
Parenteral Nutrition Management
Parenteral nutrition delivered via central venous access provides dextrose (carbohydrate), amino acids (protein), lipid emulsions (fat), electrolytes, vitamins, and trace elements. Individualized PN compounding based on daily metabolic and electrolyte monitoring is standard at academic medical centers; commercially pre-mixed PN formulations (Kabiven, StructoKabiven from Fresenius Kabi; Clinimix from Baxter) offer convenience for hospitals with lower PN volumes. Peripheral parenteral nutrition (PPN) — via peripheral IV — is limited to <900 mOsm/L to avoid phlebitis and appropriate only for 1–2 week supplemental use. PN requires strict CLABSI prevention protocols (vascular access supplies from our catalog) and pharmacy-managed sterility protocols.
